PMHNP Scope of Practice for General Psychiatry

If you’re a psychiatrist or PMHNP considering telehealth, you’ve probably asked yourself: ‘Can I legally prescribe ADHD medications, benzodiazepines, or buprenorphine via video visits?’

The short answer in 2026: Yes—but the rules are changing fast, and what’s legal in one state might not fly in another.

Here’s what you need to know to stay compliant, protect your license, and build a sustainable telepsychiatry practice.

The Current State of Federal Telehealth Prescribing (Through December 2026)

Good news first: The DEA and HHS just extended COVID-era telehealth flexibilities through December 31, 2026. This means you can continue prescribing Schedule II–V controlled substances (stimulants, benzodiazepines, buprenorphine, etc.) via telehealth without requiring an initial in-person exam.

This extension—announced January 2, 2026—gives providers breathing room while permanent regulations are finalized. But don’t get too comfortable. These are temporary rules, and what comes next will fundamentally reshape telepsychiatry.

What the DEA’s Proposed Permanent Rules Mean for You

In January 2025, the DEA unveiled three proposed rules that will eventually replace the temporary extensions:

1. Buprenorphine for Opioid Use Disorder
Providers could initiate buprenorphine via telehealth (including audio-only) and continue for up to 6 months before requiring an in-person visit. This is huge for addiction psychiatry—it acknowledges that telemedicine works for MAT and removes barriers to treatment.

2. Special Telemedicine Registration
Here’s where it gets interesting for general psychiatry. The DEA proposes creating a Special Telemedicine Prescriber Registration that would allow certain providers to prescribe controlled substances to new patients via telehealth without ever seeing them in person.

For Schedule II substances (stimulants, etc.), eligibility would initially be limited to:

• Board-certified psychiatrists
• Hospice/palliative care physicians
• Long-term care facility physicians
• Pediatricians (for specific medications)

Translation: If you’re a psychiatrist, you’d be able to obtain this special registration and legally prescribe Adderall for ADHD via telehealth indefinitely. That’s a game-changer.

The catch? Telehealth platforms would be required to register with the DEA for the first time, and there would be a national PDMP to track prescriptions across state lines. More oversight, but clearer rules.

3. VA Continuity of Care
If a VA patient had an in-person exam with any VA clinician, any VA telehealth provider could prescribe controlled substances to that patient—even across state lines. This mainly affects federal VA providers, but it signals DEA’s willingness to support continuity of care in large health systems.

Timeline: These are proposed rules currently under public comment. Expect finalization sometime in 2026, which is why the temporary extension runs through year-end.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Ryan Haight Act: What You’re Actually Navigating

Before COVID, the Ryan Haight Act of 2008 required at least one in-person medical evaluation before prescribing controlled substances via the internet. The law was designed to shut down pill mills, but it also created a massive barrier to legitimate telepsychiatry.

The Act included exceptions (like special DEA telemedicine registration), but the DEA never actually implemented the registration process—until now.

Current reality: The in-person requirement is suspended under federal emergency waivers extended through 2026. Once permanent rules take effect, you’ll either need:

• An in-person visit (at some point), OR
• The new Special Telemedicine Registration

Important distinction: If a patient was ever seen in person by any provider, you can prescribe controlled medications via telehealth with no federal restrictions (state laws still apply). The Ryan Haight Act only governs prescribing to patients who have never had an in-person evaluation.

State Laws: Where Things Get Complicated

Federal law sets the floor—states can be stricter, but not more permissive. Let’s break down the key states where most telepsychiatry happens:

California: Telehealth-Friendly with Strong PDMP Requirements

The Bottom Line: No special restrictions on telehealth prescribing beyond federal law. Standard of care applies whether you’re seeing patients in person or via video.

Key Requirements:

• CURES PDMP: You must check California’s prescription monitoring database before prescribing any Schedule II–IV controlled substance to a new patient, and every 4 months for ongoing treatment
• 100% e-prescribing (as of 2022)—paper scripts are essentially banned
• Valid California medical license (no special telehealth license exists)

PMHNP Scope: California is transitioning to full practice authority. Experienced NPs (3+ years) can now practice independently in group settings, and by 2026, they’ll be able to open solo practices without physician oversight. This is huge for scaling telehealth services in California.

Pro tip: California joined the Interstate Medical Licensure Compact (IMLC) in 2022, making it easier to obtain multi-state licenses for telepsychiatry.

Texas: NP Restrictions Make This Tricky

The Bottom Line: Telehealth prescribing is legal, but NPs and PAs cannot prescribe Schedule II drugs outside hospital or hospice settings. That means stimulants for ADHD must be handled by physicians.

Key Requirements:

• Real-time audio-video exam required (mental health exempt from needing an in-person presenter)
• Texas PMP check mandatory before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol
• NPs/PAs require physician supervision for all practice
• No telemedicine for chronic pain prescriptions without an in-person visit

Practical Impact: If you’re running a telehealth platform in Texas, you need MDs on staff to handle stimulant prescriptions. Many platforms pair NPs with psychiatrists specifically for this reason.

What about chronic pain? Texas law prohibits prescribing controlled substances for chronic pain via telemedicine without a documented in-person evaluation. This mainly affects pain management but could intersect with psychiatry in cases of complex somatic symptom disorders.

Florida: The Psychiatric Exception

The Bottom Line: Florida carved out a specific exception for psychiatric treatment that makes telepsychiatry uniquely viable here.

Key Rule: You cannot prescribe Schedule II controlled substances via telehealth UNLESS it’s for:

1. Psychiatric disorder treatment
2. Inpatient hospital care
3. Hospice care
4. Nursing home resident care

Since ADHD is a psychiatric condition, you’re covered. But if you prescribed oxycodone for pain via telehealth, that would violate Florida law.

Out-of-State Providers: Florida offers a unique out-of-state telehealth registration that allows licensed providers from other states to treat Florida patients without obtaining a full Florida license—but the same prescribing restrictions apply.

PMHNP Scope: Florida’s 2020 autonomous APRN law excluded psychiatric NPs. PMHNPs still require a protocol agreement with a supervising physician.

Don’t forget: Check Florida’s E-FORCSE PDMP before prescribing any controlled substance to patients age 16+.

New York: Clean Rules, Strict PDMP

The Bottom Line: No special telehealth restrictions. Standard of care applies. Video exam establishes a valid patient relationship.

Key Requirements:

• Mandatory I-STOP PMP check before prescribing every Schedule II, III, or IV controlled substance
• 100% e-prescribing (since 2016)—one of the strictest mandates in the country
• Valid NY medical license required (no special telehealth license)

PMHNP Scope: Experienced NPs (3,600+ hours) can practice fully independently, including prescribing controlled substances. This makes New York one of the best states for psychiatric NP telehealth.

Note: New York is not in the IMLC, so out-of-state physicians must go through the full licensing process.

Pennsylvania: Legal Gray Zone

The Bottom Line: Telehealth is allowed under general medical board authority, but Pennsylvania lacks comprehensive telehealth legislation (as of 2025).

Key Requirements:

• Standard of care must be met (video exam acceptable)
• PA PMP check required before prescribing opioids or benzodiazepines
• E-prescribing mandatory for Schedule II–V (since 2019)

PMHNP Scope: NPs need collaborative agreements with at least one physician (some sources say two for prescriptive authority). Schedule II limited to 30-day supply; Schedule III–IV up to 90 days.

What’s coming: Telehealth bills have stalled in the legislature for years. If Pennsylvania finally passes comprehensive telehealth law, expect formal consent requirements and clearer guidelines.

Illinois: Full Practice Authority with a Twist

The Bottom Line: No state restrictions on telehealth prescribing beyond federal law. Illinois is relatively progressive.

Key Requirements:

• IL PMP check mandatory each time before prescribing opioids
• E-prescribing required for all controlled substances (as of 2023)

PMHNP Scope: NPs can obtain Full Practice Authority after 4,000 clinical hours and additional training. However, even FPA NPs must enter a ‘consultation relationship’ with a physician to prescribe benzodiazepines or Schedule II narcotics—and they’re limited to 30-day supplies of those medications.

Practical note: The benzo restriction could affect anxiety treatment protocols. Make sure your NPs understand the consultation requirement.

Psychiatrist vs. PMHNP: Understanding Scope Differences

Psychiatrists (MD/DO)

• Full independent practice authority in all 50 states
• Can prescribe all Schedule II–V controlled substances consistent with DEA and state rules
• No supervision or collaboration requirements
• Primary regulatory concerns: DEA registration, state medical license, PDMP compliance

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

Scope varies dramatically by state:

Full Practice States (after experience):

• New York: 3,600 hours
• California: Phasing in through 2026
• Illinois: 4,000 hours + extra training (with benzo restrictions)

Restricted Practice States:

• Texas: Must have physician supervision; cannot prescribe Schedule II in outpatient settings
• Florida: Requires collaborative agreement; psychiatric NPs excluded from autonomous practice law
• Pennsylvania: Collaborative agreement required; limited Schedule II authority

What this means for platforms: If you’re recruiting providers, you need to account for these differences. A PMHNP in Texas needs a supervising physician arrangement. A PMHNP in New York with 3,600 hours can operate completely independently.

Compliance Essentials: What You Must Do

1. Check Your State’s PDMP—Every Time

Nearly every state now requires PDMP checks before prescribing controlled substances. Requirements vary:

• California: Check before first Rx and every 4 months
• New York: Check before every Schedule II–IV prescription
• Texas, Pennsylvania, Florida: Check before opioids and/or benzodiazepines

Most states now participate in interstate PDMP data sharing, so you can see if patients obtained controlled meds in other states.

2. Use E-Prescribing (It’s Usually the Law)

Federal law requires e-prescribing for Medicare Part D. Most states have independent e-prescribing mandates. Paper scripts are essentially obsolete for controlled substances.

Your e-prescribing system must be DEA-compliant (two-factor authentication, secure transmission).

3. Complete DEA Training Requirements

Since 2023, all DEA registrants must complete a one-time 8-hour training on substance use disorders and appropriate prescribing before DEA renewal. This came from the MATE Act (Medication Access and Training Expansion).

Board-certified addiction psychiatrists are exempt (their specialty credential counts).

4. Document Thoroughly

The fact that you’re conducting the exam via video doesn’t lower the standard of care. Document:

• Chief complaint and psychiatric history
• Mental status examination
• Rationale for controlled substance prescription
• Discussion of risks, benefits, alternatives
• Follow-up plan

This is your protection if a state board ever questions your prescribing.

5. Obtain Proper Informed Consent

Many states require specific consent for telehealth services. Best practice: document that you:

• Explained telehealth format and limitations
• Verified patient identity and location
• Provided your license number and state
• Discussed emergency protocols

The Economics: Why Telehealth Platforms Make Sense

Let’s talk business. Many psychiatrists ask: ‘Should I build my own telehealth practice or join a platform?’

DIY marketing reality check:

• Google Ads for mental health keywords: $15–40+ per click
• Most clicks don’t convert to booked patients
• Realistic cost per booked patient through PPC: $200–400+
• SEO takes 6–12 months of consistent investment before generating meaningful patient flow
• Psychology Today directory fees: Monthly subscription plus you compete with hundreds of other providers on the same page
• Zocdoc: Charges per booking ($35–100+) plus monthly subscription

Total monthly marketing spend for solo providers: Easily $3,000–5,000 with uncertain ROI.

The platform model: Pay only when a qualified patient books with you. No upfront marketing spend. No wasted ad dollars on clicks that don’t convert. Pre-qualified patients already matched to your specialty and availability.

Klarity Health’s approach:

• Pay-per-appointment model (similar to Zocdoc’s booking fee structure)
• No monthly subscription fees or minimum spend
• Built-in telehealth infrastructure (no separate EMR or video platform costs)
• Handles all patient acquisition and marketing
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you see patients

Why this matters: Instead of gambling $50,000/year on marketing with no guarantee of results, you pay a standard fee per new patient lead. That’s guaranteed ROI versus marketing risk.

For providers just starting out or those looking to scale without hiring a marketing team, platforms remove the patient acquisition burden entirely.

What’s Coming: Prepare for 2027

The DEA’s permanent rules will likely take effect in 2027. Here’s what to expect:

1. Special Telemedicine Registration for psychiatrists to prescribe Schedule II without in-person exams
2. Platform registration requirements—telehealth companies will need DEA registration
3. National PDMP integration across all states
4. 6-month rule for buprenorphine—audio-only allowed for initial 6 months, then in-person required
5. Possible annual reporting requirements for telehealth controlled substance prescribing

Smart move now: Stay informed through DEA announcements, participate in public comment periods, and ensure your practice systems (documentation, PDMP checks, e-prescribing) are already locked in.

FAQ: Telehealth Controlled Substance Prescribing

Can I prescribe Adderall via telehealth to a new patient in 2026?
Yes, under current federal emergency waivers (extended through December 31, 2026). State law may impose additional requirements. For example, it’s allowed in California, New York, and Florida (psychiatric exception), but in Texas, only an MD can prescribe Schedule II stimulants in outpatient settings—not an NP.

Do I need an in-person visit before prescribing controlled substances via telehealth?
Not under current federal rules (through 2026). Once permanent DEA rules take effect, psychiatrists will likely be able to obtain a Special Telemedicine Registration to continue prescribing Schedule II without in-person exams. For other providers or medications, an in-person visit may eventually be required (e.g., buprenorphine after 6 months).

Can I prescribe buprenorphine for opioid use disorder via audio-only phone calls?
Currently yes, and the DEA’s proposed permanent rule would extend this—allowing up to 6 months of buprenorphine treatment via audio-only before requiring in-person evaluation.

What happens if the DEA extensions expire and permanent rules aren’t finalized?
The DEA has shown commitment to avoiding care disruptions. They’ve extended temporary waivers four times already. If needed, they’ll likely issue another extension rather than creating a sudden cliff where millions of patients lose access.

Which states have the most restrictive telehealth prescribing laws?
Texas (NPs can’t prescribe Schedule II outpatient), Florida (Schedule II only for specific categories including psychiatry), and Pennsylvania (no comprehensive telehealth law, relies on board guidance). Always verify current state medical board rules.

Do PMHNPs face different rules than psychiatrists?
Absolutely. Psychiatrists have uniform federal scope across states (full prescribing authority). PMHNPs face state-by-state scope of practice variations—from full independence (New York, California phasing in) to restricted practice requiring physician supervision (Texas, Florida).

Can I treat patients in other states via telehealth?
Only if you’re licensed in the state where the patient is physically located. Some states (like Florida) offer out-of-state telehealth registration. Interstate Medical Licensure Compact (IMLC) can streamline obtaining multiple state licenses, but you still need separate licenses for each state.

Are there risks to my DEA license from telehealth prescribing?
Yes, if you don’t follow proper procedures. Common violations: prescribing without adequate evaluation, failing to check PDMP, over-prescribing controlled substances, or prescribing outside your scope. Document thoroughly, use clinical judgment, and follow all federal and state requirements.

Ready to Build a Compliant, Profitable Telepsychiatry Practice?

The regulations are complex—but the opportunity is massive. Mental health demand has never been higher, and telehealth has permanently changed how psychiatry is delivered.

Klarity Health handles the compliance heavy lifting so you can focus on patient care. Our platform:

• Ensures you’re matched with patients in states where you’re licensed
• Provides pre-screened, qualified patients ready to book
• Handles all billing, insurance verification, and administrative overhead
• Offers built-in telehealth infrastructure that’s HIPAA-compliant
• Keeps you updated on changing state and federal regulations

You see patients. We handle everything else.

Join hundreds of psychiatrists and PMHNPs who’ve scaled their practices through Klarity without the marketing headaches, compliance confusion, or patient acquisition costs.

Explore Klarity Health’s Provider Network →

Citations

1. U.S. Department of Health and Human Services. (January 2, 2026). ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026.’ Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration. (January 16, 2025). ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Lifesaving Care.’ Retrieved from https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. Florida Legislature. (2025). Florida Statutes §456.47 – Use of telehealth to provide services. Retrieved from http://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

4. Akerman LLP. (March 2023). ‘Harmonizing Federal and Florida Laws on Prescribing Controlled Substances Through Telehealth.’ Retrieved from https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html

5. Texas Medical Board. (Updated 2024). ‘Prescriptive Authority and Supervision FAQs.’ Retrieved from https://www.tmb.texas.gov/resources/for-applicants-and-licensees/prescribing-and-supervision

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=WASHINGTON%E2%80%94JANUARY%202%2C%202026%E2%80%94The%20U,while%20permanent%20rules%20are%20finalized
• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,while%20permanent%20rules%20are%20finalized
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=Expansion%20of%20Buprenorphine%20Treatment%20via,Telemedicine%20Encounter
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=For%20the%20first%20time%20online,being%20of%20patients
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=In%20developing%20these%20rules%2C%20DEA,person%20by%20the%20medical%20provider
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=telehealth%20to%20prescribe%20schedules%20III,one%20of%20the%20following%20categories
• https://www.jdsupra.com/legalnews/states-and-feds-signal-big-changes-to-9301791/#:~:text=of%20Ohio%E2%80%99s%20new%20telehealth%20prescribing,substance%20use%20disorder%20treatment%2C%20is
• https://www.akerman.com/en/perspectives/hrx-harmonizing-federal-and-florida-laws-on-prescribing-controlled-substances-through-telehealth.html#:~:text=No%20special%20registration%20is%20required,the%20State%20to%20do%20so
• https://www.tebra.com/theintake/checklists-and-guides/legal-and-compliance/nurse-practitioner-laws-by-state#:~:text=,start%20their%20own%20medical%20practices